$MNKD Company News Skullcandy gains on upgrade
Post# of 145254
Posted On: 09/19/2014 1:35:46 PM
$MNKD Company News
Skullcandy gains on upgrade,Tesla reverses gains 2:37 p.m. Aug. 12, 2014 - Sue Chang
U.S. small caps lead broad stock-market gains 4:09 p.m. Aug. 11, 2014 - Anora Mahmudova
Kinder Morgan soars, Tesla rallies on upgrade 12:46 p.m. Aug. 11, 2014 - Sue Chang
MannKind shares soar on Sanofi deal; investors ignore earnings report 10:10 a.m. Aug. 11, 2014 - Russ Britt
Super-Moon illusion or buy the dips on this stock market? 7:52 a.m. Aug. 11, 2014 - Barbara Kollmeyer
MannKind shares soar 23% on Sanofi deal over Afrezza 7:04 a.m. Aug. 11, 2014 - Silvia Ascarelli
Sanofi, MannKind to commercialize Afrezza insulin therapy 5:32 a.m. Aug. 11, 2014 - Silvia Ascarelli
Puma Biotech’s blast-off is not a typical short squeeze 12:10 p.m. July 23, 2014 - Tomi Kilgore
S&P 500 posts strongest 2nd quarter since 2009: Stock market live blog recap 3:33 p.m. June 30, 2014 - blogs.marketwatch.com
MannKind, GoPro rise; Yahoo gains on upgrade 12:02 p.m. June 30, 2014 - Sue Chang
MannKind shares up 23.1% in premarket trade 7:19 a.m. June 30, 2014 - Ciara Linnane
Six more bull months ahead, and GoPro keeps on going 6:28 a.m. June 30, 2014 - Sara Sjolin
MannKind wins approval for its inhaled insulin — and its stock drops? 4:30 p.m. June 27, 2014 - Russ Britt
DuPont falls on outlook; Michaels debuts 4:08 p.m. June 27, 2014 - Sue Chang
3 overlooked stocks loved by top-ranked advisers 3:09 p.m. April 25, 2014 - Mark Hulbert
Tesla, Facebook seesaw; Questcor surges on deal 3:54 p.m. April 7, 2014 - Sue Chang
MannKind drops after FDA says its review on drug will last until July 1:46 p.m. April 7, 2014 - Russ Britt
Stock futures drop as earnings season looms 9:20 a.m. April 7, 2014 - Sara Sjolin
MannKind drops 12% after FDA review extension 7:15 a.m. April 7, 2014 - Ben Eisen
MannKind drops 16% after FDA review extension 7:01 a.m. April 7, 2014 - Ben Eisen
Why You Shouldn't Bet Against MannKind (MNKD) Stock - Tale of the Tape 8:39 a.m. Sept. 18, 2014 - Zacks.com
MannKind: Seeing The Forest Through The Trees 6:37 p.m. Sept. 16, 2014 - Seeking Alpha
Al Mann Trounces The Afrezza Bear Case In Interview With Noted Diabetes Educator 6:01 p.m. Sept. 16, 2014 - Seeking Alpha
5 Stocks With Awful Sales Growth — HTS MITT UEC MNKD CTEL 4:45 a.m. Sept. 15, 2014 - InvestorPlace.com
New Diabetes Drugs Gain Approval - Florins Versus Oral Insulin 2:15 p.m. Sept. 14, 2014 - Seeking Alpha
MannKind In Turmoil: Is It Time To Buy Or Sell? 7:52 a.m. Sept. 12, 2014 - Seeking Alpha
MannKind: Nothing But Good News, Trading Volume Drops, Short Interest Remains Sky High 3:30 p.m. Sept. 11, 2014 - Seeking Alpha
Could A MannKind Short Squeeze Be On Its Way? 11:04 a.m. Sept. 11, 2014 - Seeking Alpha
Short Sellers Remain Vigilant Against Biotechs 9:45 a.m. Sept. 11, 2014 - 247WallSt.com
Top 3 Low-Risk Mutual Funds With High Returns 8:18 a.m. Sept. 11, 2014 - InvestorPlace.com
MannKind's Management Presents at Morgan Stanley Global Healthcare Conference (Transcript) 5:48 p.m. Sept. 9, 2014 - Seeking Alpha
5 Stocks With Awful Sales Growth — HTS MITT UEC MNKD CTEL 5:30 a.m. Sept. 8, 2014 - InvestorPlace.com
Cramer's Mad Money - 8 Things To Watch In The Week Ahead (9/5/14) 3:58 a.m. Sept. 8, 2014 - Seeking Alpha
5 Stocks With Poor Sales Growth — HTS MITT UEC MNKD CTEL 2:15 p.m. Sept. 1, 2014 - InvestorPlace.com
Rising Short Interest in Biotech Stocks 9:42 a.m. Aug. 27, 2014 - 247WallSt.com
Biggest Movers in Healthcare Stocks Now – MNKD RMD PRGO EXAS 8:30 a.m. Aug. 27, 2014 - InvestorPlace.com
MannKind Is Ripe: Let's Do Big Things, But Fundamentals First 8:49 a.m. Aug. 26, 2014 - Seeking Alpha
Biggest Movers in Healthcare Stocks Now – ACHN IRWD PCRX CBST 1:45 p.m. Aug. 25, 2014 - InvestorPlace.com
MannKind: Moving From Short To Long? 1:04 p.m. Aug. 25, 2014 - Seeking Alpha
5 Stocks With Bad Sales Growth — HTS MITT UEC MNKD CTEL 6:00 a.m. Aug. 25, 2014 - InvestorPlace.com
Critical Alerts For Intel, Zynga, Isis Pharmaceuticals, Arrowhead Research and MannKind Released By InvestorsObserver 9:31 a.m. Sept. 16, 2014 - PR Newswire - PRF
Technical Coverage on Biotech Equities - Galena Biopharma, Gilead Sciences, MannKind, Orexigen Therapeutics, and IsoRay 9:05 a.m. Sept. 3, 2014 - PR Newswire - PRF
MannKind Corporation to Present at Morgan Stanley Global Healthcare Conference 5:01 p.m. Sept. 2, 2014 - GlobeNewswire
Critical Alerts For MannKind, Best Buy, Splunk, Rite Aid and Allscripts Released By InvestorsObserver 9:31 a.m. Aug. 28, 2014 - PR Newswire - PRF
Drug Approvals & Updates, Licensing Agreements, and Upcoming Conferences - Research Reports on Tekmira, MannKind, Eli Lilly, GSK and Cigna 8:30 a.m. Aug. 14, 2014 - PR Newswire - PRF
Critical Alerts For MannKind, Kinder Morgan, Kohls, Maxim Integrated Products and United Technologies. Released By InvestorsObserver 9:31 a.m. Aug. 12, 2014 - PR Newswire - PRF
MannKind Corporation Reports 2014 Second Quarter Financial Results 9:01 a.m. Aug. 11, 2014 - GlobeNewswire
Sanofi and MannKind Announce Global Licensing Agreement for Afrezza® (insulin human) Rapid-Acting Inhaled Insulin 7:00 a.m. Aug. 11, 2014 - PR Newswire - PRF
Sanofi and MannKind Announce Global Licensing Agreement for Afrezza(R) (insulin human) Rapid-Acting Inhaled Insulin 1:13 a.m. Aug. 11, 2014 - GlobeNewswire
MannKind Corporation to Hold 2014 Second Quarter Financial Results Conference Call on August 11, 2014 5:00 p.m. Aug. 5, 2014 - GlobeNewswire
Biotech Stocks Technical Data -- MannKind, ARIAD Pharma, Galena Biopharma, Geron, and Peregrine Pharma 9:00 a.m. Aug. 1, 2014 - PR Newswire - PRF
Critical Alerts For MannKind, CVS Caremark, Express Scripts, Cheniere Energy, and HomeAway Released By InvestorsObserver 9:31 a.m. July 21, 2014 - PR Newswire - PRF
NDA Submission, Results Release Schedules, FDA Grants and Approvals, and Agreements - Analyst Notes on Gilead, Biogen Idec, Amgen, Illumina and MannKind 5:20 a.m. July 4, 2014 - PR Newswire - PRF
MannKind Corp Analyst Report; Afrezza is Approved and Future Developments by BrokerBank Securities, Inc. 11:15 a.m. July 3, 2014 - PR Newswire - PRF
Critical Alerts For MannKind, AOL, Plug Power, Ctrip.com, and 58.com Released By InvestorsObserver 9:31 a.m. July 1, 2014 - PR Newswire - PRF
MannKind Corporation Announces FDA Approval of AFREZZA(R); A Novel, Rapid-Acting Inhaled Insulin for the Treatment of Diabetes 5:07 p.m. June 27, 2014 - GlobeNewswire
Leadership Appointments, Approved Acquisitions, Licensing Agreements, Technical UPdate, and Response to Tender Offer Announcement - Analyst Notes on Actavis, Forest, Vertex, MannKind and Gentiva 5:20 a.m. June 26, 2014 - PR Newswire - PRF
Critical Alerts For Netflix, MannKind, Dish Network, Illumina, and Anheuser-Busch InBev Technology Released By InvestorsObserver 9:31 a.m. June 6, 2014 - PR Newswire - PRF
MannKind to Present at Upcoming Conferences 9:01 a.m. May 27, 2014 - GlobeNewswire
Reveal Insider Trading for Facebook, MannKind, QUALCOMM, American Realty Capital Properties, salesforce.com, and Symantec 8:55 a.m. May 22, 2014 - PR Newswire - PRF
Skullcandy gains on upgrade,Tesla reverses gains 2:37 p.m. Aug. 12, 2014 - Sue Chang
U.S. small caps lead broad stock-market gains 4:09 p.m. Aug. 11, 2014 - Anora Mahmudova
Kinder Morgan soars, Tesla rallies on upgrade 12:46 p.m. Aug. 11, 2014 - Sue Chang
MannKind shares soar on Sanofi deal; investors ignore earnings report 10:10 a.m. Aug. 11, 2014 - Russ Britt
Super-Moon illusion or buy the dips on this stock market? 7:52 a.m. Aug. 11, 2014 - Barbara Kollmeyer
MannKind shares soar 23% on Sanofi deal over Afrezza 7:04 a.m. Aug. 11, 2014 - Silvia Ascarelli
Sanofi, MannKind to commercialize Afrezza insulin therapy 5:32 a.m. Aug. 11, 2014 - Silvia Ascarelli
Puma Biotech’s blast-off is not a typical short squeeze 12:10 p.m. July 23, 2014 - Tomi Kilgore
S&P 500 posts strongest 2nd quarter since 2009: Stock market live blog recap 3:33 p.m. June 30, 2014 - blogs.marketwatch.com
MannKind, GoPro rise; Yahoo gains on upgrade 12:02 p.m. June 30, 2014 - Sue Chang
MannKind shares up 23.1% in premarket trade 7:19 a.m. June 30, 2014 - Ciara Linnane
Six more bull months ahead, and GoPro keeps on going 6:28 a.m. June 30, 2014 - Sara Sjolin
MannKind wins approval for its inhaled insulin — and its stock drops? 4:30 p.m. June 27, 2014 - Russ Britt
DuPont falls on outlook; Michaels debuts 4:08 p.m. June 27, 2014 - Sue Chang
3 overlooked stocks loved by top-ranked advisers 3:09 p.m. April 25, 2014 - Mark Hulbert
Tesla, Facebook seesaw; Questcor surges on deal 3:54 p.m. April 7, 2014 - Sue Chang
MannKind drops after FDA says its review on drug will last until July 1:46 p.m. April 7, 2014 - Russ Britt
Stock futures drop as earnings season looms 9:20 a.m. April 7, 2014 - Sara Sjolin
MannKind drops 12% after FDA review extension 7:15 a.m. April 7, 2014 - Ben Eisen
MannKind drops 16% after FDA review extension 7:01 a.m. April 7, 2014 - Ben Eisen
Why You Shouldn't Bet Against MannKind (MNKD) Stock - Tale of the Tape 8:39 a.m. Sept. 18, 2014 - Zacks.com
MannKind: Seeing The Forest Through The Trees 6:37 p.m. Sept. 16, 2014 - Seeking Alpha
Al Mann Trounces The Afrezza Bear Case In Interview With Noted Diabetes Educator 6:01 p.m. Sept. 16, 2014 - Seeking Alpha
5 Stocks With Awful Sales Growth — HTS MITT UEC MNKD CTEL 4:45 a.m. Sept. 15, 2014 - InvestorPlace.com
New Diabetes Drugs Gain Approval - Florins Versus Oral Insulin 2:15 p.m. Sept. 14, 2014 - Seeking Alpha
MannKind In Turmoil: Is It Time To Buy Or Sell? 7:52 a.m. Sept. 12, 2014 - Seeking Alpha
MannKind: Nothing But Good News, Trading Volume Drops, Short Interest Remains Sky High 3:30 p.m. Sept. 11, 2014 - Seeking Alpha
Could A MannKind Short Squeeze Be On Its Way? 11:04 a.m. Sept. 11, 2014 - Seeking Alpha
Short Sellers Remain Vigilant Against Biotechs 9:45 a.m. Sept. 11, 2014 - 247WallSt.com
Top 3 Low-Risk Mutual Funds With High Returns 8:18 a.m. Sept. 11, 2014 - InvestorPlace.com
MannKind's Management Presents at Morgan Stanley Global Healthcare Conference (Transcript) 5:48 p.m. Sept. 9, 2014 - Seeking Alpha
5 Stocks With Awful Sales Growth — HTS MITT UEC MNKD CTEL 5:30 a.m. Sept. 8, 2014 - InvestorPlace.com
Cramer's Mad Money - 8 Things To Watch In The Week Ahead (9/5/14) 3:58 a.m. Sept. 8, 2014 - Seeking Alpha
5 Stocks With Poor Sales Growth — HTS MITT UEC MNKD CTEL 2:15 p.m. Sept. 1, 2014 - InvestorPlace.com
Rising Short Interest in Biotech Stocks 9:42 a.m. Aug. 27, 2014 - 247WallSt.com
Biggest Movers in Healthcare Stocks Now – MNKD RMD PRGO EXAS 8:30 a.m. Aug. 27, 2014 - InvestorPlace.com
MannKind Is Ripe: Let's Do Big Things, But Fundamentals First 8:49 a.m. Aug. 26, 2014 - Seeking Alpha
Biggest Movers in Healthcare Stocks Now – ACHN IRWD PCRX CBST 1:45 p.m. Aug. 25, 2014 - InvestorPlace.com
MannKind: Moving From Short To Long? 1:04 p.m. Aug. 25, 2014 - Seeking Alpha
5 Stocks With Bad Sales Growth — HTS MITT UEC MNKD CTEL 6:00 a.m. Aug. 25, 2014 - InvestorPlace.com
Critical Alerts For Intel, Zynga, Isis Pharmaceuticals, Arrowhead Research and MannKind Released By InvestorsObserver 9:31 a.m. Sept. 16, 2014 - PR Newswire - PRF
Technical Coverage on Biotech Equities - Galena Biopharma, Gilead Sciences, MannKind, Orexigen Therapeutics, and IsoRay 9:05 a.m. Sept. 3, 2014 - PR Newswire - PRF
MannKind Corporation to Present at Morgan Stanley Global Healthcare Conference 5:01 p.m. Sept. 2, 2014 - GlobeNewswire
Critical Alerts For MannKind, Best Buy, Splunk, Rite Aid and Allscripts Released By InvestorsObserver 9:31 a.m. Aug. 28, 2014 - PR Newswire - PRF
Drug Approvals & Updates, Licensing Agreements, and Upcoming Conferences - Research Reports on Tekmira, MannKind, Eli Lilly, GSK and Cigna 8:30 a.m. Aug. 14, 2014 - PR Newswire - PRF
Critical Alerts For MannKind, Kinder Morgan, Kohls, Maxim Integrated Products and United Technologies. Released By InvestorsObserver 9:31 a.m. Aug. 12, 2014 - PR Newswire - PRF
MannKind Corporation Reports 2014 Second Quarter Financial Results 9:01 a.m. Aug. 11, 2014 - GlobeNewswire
Sanofi and MannKind Announce Global Licensing Agreement for Afrezza® (insulin human) Rapid-Acting Inhaled Insulin 7:00 a.m. Aug. 11, 2014 - PR Newswire - PRF
Sanofi and MannKind Announce Global Licensing Agreement for Afrezza(R) (insulin human) Rapid-Acting Inhaled Insulin 1:13 a.m. Aug. 11, 2014 - GlobeNewswire
MannKind Corporation to Hold 2014 Second Quarter Financial Results Conference Call on August 11, 2014 5:00 p.m. Aug. 5, 2014 - GlobeNewswire
Biotech Stocks Technical Data -- MannKind, ARIAD Pharma, Galena Biopharma, Geron, and Peregrine Pharma 9:00 a.m. Aug. 1, 2014 - PR Newswire - PRF
Critical Alerts For MannKind, CVS Caremark, Express Scripts, Cheniere Energy, and HomeAway Released By InvestorsObserver 9:31 a.m. July 21, 2014 - PR Newswire - PRF
NDA Submission, Results Release Schedules, FDA Grants and Approvals, and Agreements - Analyst Notes on Gilead, Biogen Idec, Amgen, Illumina and MannKind 5:20 a.m. July 4, 2014 - PR Newswire - PRF
MannKind Corp Analyst Report; Afrezza is Approved and Future Developments by BrokerBank Securities, Inc. 11:15 a.m. July 3, 2014 - PR Newswire - PRF
Critical Alerts For MannKind, AOL, Plug Power, Ctrip.com, and 58.com Released By InvestorsObserver 9:31 a.m. July 1, 2014 - PR Newswire - PRF
MannKind Corporation Announces FDA Approval of AFREZZA(R); A Novel, Rapid-Acting Inhaled Insulin for the Treatment of Diabetes 5:07 p.m. June 27, 2014 - GlobeNewswire
Leadership Appointments, Approved Acquisitions, Licensing Agreements, Technical UPdate, and Response to Tender Offer Announcement - Analyst Notes on Actavis, Forest, Vertex, MannKind and Gentiva 5:20 a.m. June 26, 2014 - PR Newswire - PRF
Critical Alerts For Netflix, MannKind, Dish Network, Illumina, and Anheuser-Busch InBev Technology Released By InvestorsObserver 9:31 a.m. June 6, 2014 - PR Newswire - PRF
MannKind to Present at Upcoming Conferences 9:01 a.m. May 27, 2014 - GlobeNewswire
Reveal Insider Trading for Facebook, MannKind, QUALCOMM, American Realty Capital Properties, salesforce.com, and Symantec 8:55 a.m. May 22, 2014 - PR Newswire - PRF
(0)
(0)